Cardiovascular, Metabolic, and Rare Side Effects Both semaglutide and tirzepatide carry cardiovascular benefits in diabetic and obesity trials, but rare risks include pancreatitis, gallbladder disease, and thyroid C-cell concerns (animal studies, not proven in humans)
it enhances glucose-dependent insulin secretion from pancreatic beta cells
If you are particularly sensitive, especially during early doses or dose escalations , the 1 to 3 hour nausea window might overlap with your attempts to fall asleep
Is it stable
Retatrutide Is Not Yet Approved Explore Proven Medical Weight Loss Options If you're exploring future options for weight loss treatment, youve likely heard about Retatrutide
Prioritize fiber-rich vegetables, fruit, legumes, and whole grains when possible